To determine the role of
ceruloplasmin (Cp) in epileptic
seizures, we used a
kainate (KA) seizure animal model and examined hippocampal samples from epileptic patients. Treatment with KA resulted in a time-dependent decrease in Cp
protein expression in the hippocampus of rats. Cp-positive cells were colocalized with neurons or reactive astrocytes in KA-treated rats and epileptic patient samples. KA-induced
seizures, initial oxidative stress (i.e.,
hydroxyl radical formation, lipid peroxidation,
protein oxidation, and synaptosomal
reactive oxygen species), altered
iron status (increasing Fe(2+) accumulation and
L-ferritin-positive reactive microglial cells and decreasing
H-ferritin-positive neurons), and impaired
glutathione homeostasis and neurodegeneration (i.e., Fluoro-Nissl and
Fluoro-Jade B staining analyses) were more pronounced in Cp
antisense oligonucleotide (ASO)- than in Cp sense
oligonucleotide-treated rats. Consistently, Cp ASO facilitated KA-induced
lactate dehydrogenase (LDH) release, Fe(2+) accumulation, and
glutathione loss in neuron-rich and mixed cultures. However, Cp ASO did not alter KA-induced LDH release or Fe(2+) accumulation in the astroglial culture, but did facilitate impairment in
glutathione homeostasis in the same culture. Importantly, treatment with human Cp
protein resulted in a significant attenuation against these neurotoxicities induced by Cp ASO. Our results suggest that Cp-mediated neuroprotection occurs via the inhibition of seizure-associated oxidative damage (including impairment in
glutathione homeostasis), Fe(2+) accumulation, and alterations in
ferritin immunoreactivity. Moreover, interactive modulation between neurons and glia was found to be important for Cp upregulation in the attenuation of epileptic damage in both animals and humans.